Medical errors on the agenda at FDA/AHRQ (Agency for Healthcare Research and Quality) meeting
This article was originally published in Clinica
Executive Summary
The US FDA and the Agency for Healthcare Research and Quality are sponsoring a two-day public workshop on avoiding errors in transfusion medicine. Issues to be addressed on the first day of the workshop include: patient and medication identification; errors in manufacturing and testing of blood and blood components, system errors and cultural factors and the role of product deviation reporting in reducing transfusion errors. The second day will focus on current and future technology trends that should help prevent transfusion errors.